• Evaluate drugs, medical devices and professional procedures with a view to their reimbursement;
• Recommend good professional practices, draw up vaccination and public health recommendations;
• Measure and improve quality in hospitals, clinics, outpatient medicine, social and medico-social establishments.

In the field of healthcare innovation, the HAS:

• Evaluates health technologies with a view to their reimbursement;
• Evaluates the eligibility of requests for forfait innovation (derogatory reimbursement scheme for innovative technologies).

In the field of business software for healthcare professionals, the HAS:

• Integrates drug databases, medical devices and associated services (BdM) on the basis of a quality charter;
• Establishes the certification procedure and reference systems for prescribing assistance software (PAS) and dispensing assistance software (DAS): ambulatory medicine PAS, hospital PAS, dispensary DAS and internal-use pharmacy DAS;
• Develops medical decision support systems: drug-indexed decision support systems (DSS) and Good practice DataSets ;
• Develops quality repositories relating to certain types of decision support systems (DSS).
• Structures coordination document templates that can be integrated into business software, exchanged via secure health messaging or shared in the shared medical record (DMP).

In the field of telehealth, the HAS:

• Promotes the proper use and quality of practices for acts of telemedicine(teleconsultation, teleexpertise and teleimaging) and activities of telecare: eligibility criteria, recommendations for implementation, patient information sheets, rapid responses under Covid-19, "patient traceur" professional practice evaluation method;
• Develops tools to support the deployment of telemedicine in France.
• Evaluates, at the initiative of operators, remote medical monitoring medical devices and associated medical services with a view to their inclusion on the dedicated reimbursement list, both for the permanent framework and, upstream, within the derogatory framework of prise en charge anticipée (PECAN).

In the field of mobile health, the HAS:

• Makes available to manufacturers and evaluators a good practice reference framework for assessing the quality of applications and connected objects in mobile health;
• Develops the medical content quality referencing for digital services in the digital health space (ENS), a service platform for citizens, and in the service package (BS), a service platform for healthcare professionals.

In the field of healthcare innovation, you can contact the HAS to:

• Consult the referentials and good practice guides that concern me;
• Anticipate the terms of access to reimbursement for my solution.

In the fields of business software, telehealth and mobile health, the HAS supports you by answering your questions sent by e-mail to: contact.mns@has-sante.fr

• If you are a publisher of a drug database, a practice or dispensary management software in the city or hospital, which allows to elaborate or deliver a medical prescription, if you are considering applying for LAP and LAD certification, the HAS answers your questions on the steps to take (approval procedure and certification procedure) and on the content of the certification referentials;
• If you offer a digital telemedicine service (teleconsultation, remote interpretation of imaging examinations...), HAS guides will enlighten you on the best practices to implement;
• If you are carrying out a telemedicine project, the safety grid will help you identify and control the specific risks of your project;
• If you're an industrialist(app designer, start-up...) or an evaluator(evaluation structures, consumer associations or medical learned societies) the good practice guidelines for mobile health applications and connected objects will enlighten you on the best practices to take into account for a safe, high-quality design. This guide aims to promote usage and reinforce confidence in connected applications and objects.

If your product falls within the scope of HAS assessment, and in particular in the context of an application for reimbursement by the French National Health Insurance, support is available at certain key moments prior to the submission of your reimbursement application. Two types of meetings are possible for technologies that fall within the scope of medical device status or involve the creation of a new professional act, depending on how far your development has progressed:

• Earlymeetings if you have a clinical study project and would like to benefit from an exchange with HAS teams and their experts on a study you wish to set up. The main aim of these meetings is to discuss the questions you have concerning the methodology of the clinical study you are planning. This type of exchange can be useful before your study begins. So it's at this point, as soon as your protocol project is constructed, that you can approach us;
• Or pre-filing appointments: these appointments are set up specifically for medical devices to help manufacturers with the technical and regulatory aspects of setting up or finalizing their dossier (LPPR scope, LATM, PECAN, dossier content in particular).

No